The Implantable Medical Devices Market: US Demand to Grow 7.7% Annually Through 2011

Reportlinker.com announces that a new market research report related to the American medical industry is now available to its catalogue.

Implantable Medical Devices

www.reportlinker.com/p061181/PRBW-US-Medical-Devices.html

If you wish to get more information on this report, then send an e-mail to Nicolas Bombourg, at nbo@reportlinker.com.

Description

US demand to grow 7.7% annually through 2011.

The publisher projects demand for implantable medical devices increasing 7.7 percent annually to $40.2 billion in 2011. An expanding prevalence of heart, orthopedic, neurological, visual and urinary disorders, coupled with ongoing improvements in the safety and effectiveness of products, will promote gains. Additionally, the rising popularity of cosmetic surgery will boost growth opportunities for breast, dermal and tissue implants. Less favorably, linkage to potentially fatal complications, along with advances in alternative drug therapies, will weaken the market for a number of implantable medical devices, especially drug-eluting coronary stents.

CRT devices to propel slowing cardiac segment.

Eroding sales of drug-eluting coronary stents will moderate overall growth opportunities for cardiac implants. Total demand posted by this product group is projected to increase 5.2 percent annually to $16.2 billion in 2011. Discontinued usage among high risk cardiac patients will cause the market for coronary drug-eluting stents to decline by $750 million in the 2006-2011 period. However, in spite of this decrease, total demand for cardiac implants will continue to rise due largely to the widening use of cardiac resynchronization therapy (CRT) devices in the treatment of congestive heart failure (CHF). CRT devices are more effective than alternative drug therapies in restoring the blood pumping capabilities of CHF patients along with reducing their risk of disease complications, such as atrial fibrillation.

Orthopedic implants offer best growth opportunities.

Demand for orthopedic implants will reach $19.1 billion in 2011, up 8.8 percent annually from 2006. Tissue and spinal implants, along with hip and shoulder replacement products, will see the fastest sales gains as advances in fusion, fixation and neurological stimulating technologies improve the success rate and cost-effectiveness of related surgical procedures. Demand for knee reconstructive implants and trauma fixation products will expand at a more moderate pace, benefitting from an increasing prevalence of deteriorated joint conditions and fracture injuries, but adversely affected by improvements in alternative drug therapies and external fixation devices.

Neurological stimulators, eye implants among other leading prospects.

Other implantable medical devices will post demand of $4.9 billion in 2011, up over 13 percent annually from 2006. Products leading growth will consist of neurological stimulators for treating epilepsy, Parkinson’s disease and other central nervous system disorders; phakic intraocular lenses for correcting nearsightedness; retinal implants for treating macular degeneration; brachytherapy for cancer indications; and cochlear devices for restoring hearing loss. These products offer significant performance and outcome advantages over alternative treatments. Among other implantable medical devices, dermal and tissue implants and silicone breast implants will fare the best in the marketplace reflecting an increasingly appearance-conscious population.

Study coverage

It presents historical demand data for the years 1996, 2001 and 2006 and forecasts for 2011 and 2016 by implant material (e.g., microelectronics, specialty metals, polymers, elastomers, ceramics) and type (e.g., cardiac, orthopedic). The study also considers market environment factors, details industry structure, evaluates company market share and profiles leading industry competitors.

Table of content

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

Economic Factors

Demographic Patterns

Health Care Trends

Health Insurance

Acute Conditions

Chronic Conditions

Cardiovascular Conditions

Coronary Heart Disease

Heart Rhythm Disorders

Peripheral Artery Disease

Valvular Heart Disease

Congestive Heart Failure

Stroke

Congenital Heart Disease

Orthopedic Conditions

Mobility Impairments

Arthritis

Osteopenia & Osteoporosis

Paget’s Disease

Neurological Conditions

Other Chronic Conditions

National Health Expenditures

Medical Providers

Hospitals

Outpatient Facilities

Skilled Nursing Homes

Physicians

Patient Activity

Hospital Activity

Outpatient Episodes

Surgical Procedures

Implant Procedures

Heart-Related Implant Procedures

Orthopedic Implant Procedures

Other Implant Procedures

Medical Product Markets

Pharmaceuticals & Biologicals

Surgical Appliances & Supplies

Surgical & Medical Instruments

Electromedical Equipment

Other Medical Products

III. MATERIALS & COMPONENTS

Microelectronic Components

Specialty Metals

Titanium

Stainless Steel

Other Metals

Polymers

Acrylics

Nylon

Polytetrafluoroethylene (PTFE)

Silicone Polymers

Sulfone-Based Resins

Thermoset Polyurethane

Ultra High Molecular Weight Polyethylene (UHMW-PE)

Other Polymers

Elastomers

Other Materials

Biologicals & Pharmaceuticals

Ceramics

Alumina

Hydroxyapatite

Zirconia

Pyrolytic Carbon

Nanotechnology

Collagen

All Other Materials

IV. PRODUCT OVERVIEW

V. CARDIAC IMPLANTS

Defibrillators & Related Devices

Cardiac Resynchronization Therapy Devices

CRT-D Types & Functions

Implantable Cardioverter Defibrillators (ICDs)

ICD Technology

ICD/CRT-D Leads

Batteries

Cardiac Stents

Drug-Eluting Coronary Stents

Peripheral Stents

Bare-Metal Coronary Stents

Carotid Stents

Pacemakers & Accessories

Heart-Related Grafts

Vascular & Endovascular Grafts

Arterial-to-Venous Grafts

Heart Valves

Vena Cava Filters

Ventricular-Assist Devices

Implantable Heart Monitors

Insertable Loop Recorders (ILRs)

Implantable Hemodynamic Monitors (IHMs)

VI. ORTHOPEDIC IMPLANTS

Reconstructive Implants

Knee Implants

Hip Implants

Shoulder Implants

Other Reconstructive Implants

Elbow Implants

Ankle Implants

All Other Joint Replacement Implants

Spinal Implants

Internal Spinal Fixation Devices

Bone Grafts & Substitutes

Natural Bone

Intravertebral Spacers

Bone Substitutes

Fusion Cages

Implantable Stimulators

Trauma Fixation Implants

Internal Fixation Devices

Bone Grafts & Substitutes

Craniomaxillofacial Implants

Bone Cement

Tissue Implants

VII. OTHER IMPLANTABLE MEDICAL DEVICES

Neurological Stimulators

Ophthalmic Implants

Intraocular Lenses

Phakic Lenses

Retinal & Other Ophthalmic Implants

Breast Implants

Drug Implants

Drug Inserts

Brachytherapy

Implantable Drug Pumps

Urological Implants

Penile Implants

Biliary Stents

Other Urological Implants

Cochlear Implants

Dermal Implants

All Other Implantable Medical Devices

VIII. INDUSTRY STRUCTURE

Medtronic

Johnson & Johnson

Boston Scientific

Stryker

Zimmer

St. Jude Medical

Synthes

Abbott Laboratories

Biomet

Smith & Nephew

Other Companies

Company Profiles

Abbott Laboratories

ABIOMED Incorporated

Advanced Medical Optics Incorporated

Advanced Neuromodulation Systems Incorporated, see St. Jude Medical Incorporated

Akzo Nobel NV

Allergan Incorporated

ALZA Corporation, see Johnson & Johnson

American Medical Systems Holdings Incorporated

Bard (CR) Incorporated

Bausch & Lomb Incorporated

Biomet Incorporated

Boston Scientific Corporation

Cochlear Limited

Codman & Shurtleff Incorporated, see Johnson & Johnson

Coloplast A/S

Conor Medsystems Incorporated, see Johnson & Johnson

Cook Group Incorporated

Cordis Corporation, see Johnson & Johnson

Cyberonics Incorporated

Davol Incorporated, see CR Bard Incorporated

DePuy Incorporated, see Johnson & Johnson

Edwards Lifesciences Corporation

EndoArd SA, see Allergan Incorporated

EndoTex Interventional Systems Incorporated, see Boston Scientific Corporation

Ethicon Endo-Surgery Incorporated, see Johnson & Johnson

Ethicon Incorporated, see Johnson & Johnson

Gore (WL) & Associates Incorporated

Groupe Corneal Laboratories, see Allergan Incorporated

Guidant Corporation, see Boston Scientific Corporation

Hand Innovations LLC, see Johnson & Johnson

Inamed Corporation, see Allergan Incorporated

Johnson & Johnson

Medtronic Incorporated

Mentor Corporation

Optobionics Corporation

Organon International Incorporated, see Akzo Nobel

OsteoBiologics Incorporated, see Smith & Nephew

Savacor Incorporated, see St. Jude Medical Incorporated

Smith & Nephew plc

St. Jude Medical Incorporated

Stryker Corporation

Synthes Incorporated

Theragenics Corporation

Zimmer Holdings Incorporated

More market research reports? Go to http://www.reportlinker.com

http://market-research.typepad.com/agricultural_chemicals/